http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

Only a few pharmacological treatments are available for treating alcohol use disorders (AUDs). Disulfiram, naltrexone and acamprosate are Food and Drug Administration (FDA)-approved and nalmefene is EMA-approved in European Union. Off-label medications, such as baclofen, gabapentin, ondansetron and topiramate are medications commonly prescribed for the treatment of AUD.

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0007079 MONDO_0007079

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

http://identifiers.org/drugbank/DB00904 DB00904

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RArHZARcje...#context context

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/category category

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/aggregator_knowledge_source aggregator_knowledge_source

https://w3id.org/biolink/infores/knowledge-collaboratory knowledge-collaboratory

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

http://www.ncbi.nlm.nih.gov/pubmed/30973369 pubmed/30973369

Vincent Emonet

2022-09-16T11:51:27.478Z

http://purl.org/np/RArHZARcje... RArHZARcje

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

http://purl.obolibrary.org/obo/NCIT_C94303 NCIT_C94303

Vincent Emonet

2022-09-16T11:51:27.478Z